Obesity disease overview: A growing driver of both morbidity and healthcare spending Obesity is a complex medical disorder that has been described as an accelerated aging condition, as it increases the risk of both morbidity and mortality from age-related chronic disease
Owing to their unique hypoglycemic mechanism, these drugs initially developed for diabetes treatment have been extensively used in patients with obesity and have obtained approval from the FDA
Figure 2 In addition, the ROC curve analysis showed potential diagnostic values of serum ALC and LC (Figure 3)
Physicians and Healthcare Givers The medical professionals at Achieve Medical weight loss Dothan are not found on the clinics webpage, as their names and credentials are not mentioned
: BPC-157
#Pfizer #NovoNordisk #Metsera To view or add a comment, sign in This Financial Times article titled "The race to launch a pill for weight loss" highlights that despite the success with injectable weight-loss drugs, pharma companies are continuing to invest heavily in orally delivered alternatives